These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 29308349)

  • 1. Influence of extracorporeal shock wave therapy (ESWT) on bone turnover markers in organisms with normal and low bone mineral density during fracture healing: a randomized clinical trial.
    Wölfl C; Schuster L; Höner B; Englert S; Klein R; Hirche C; Münzberg M; Grützner PA; Kneser U; Harhaus L
    GMS Interdiscip Plast Reconstr Surg DGPW; 2017; 6():Doc17. PubMed ID: 29308349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of bone turnover in the long bone metaphysis fractured patients with normal or low Bone Mineral Density (BMD).
    Wölfl C; Schweppenhäuser D; Gühring T; Takur C; Höner B; Kneser U; Grützner PA; Kolios L
    PLoS One; 2014; 9(5):e96058. PubMed ID: 24788647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time course of 25(OH)D3 vitamin D3 as well as PTH (parathyroid hormone) during fracture healing of patients with normal and low bone mineral density (BMD).
    Wölfl C; Englert S; Moghaddam AA; Zimmermann G; Schmidt-Gayk H; Höner B; Hogan A; Lehnhardt M; Grützner PA; Kolios L
    BMC Musculoskelet Disord; 2013 Jan; 14():6. PubMed ID: 23286544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of baseline bone turnover marker levels and response to risedronate treatment: Data from a Japanese phase III trial.
    Mawatari T; Ikemura S; Matsui G; Iguchi T; Mitsuyasu H; Kawahara S; Maehara M; Muraoka R; Iwamoto Y; Nakashima Y
    Bone Rep; 2020 Jun; 12():100275. PubMed ID: 32462056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-term effects of extracorporeal shock wave therapy on bone mineral density in postmenopausal osteoporotic patients.
    Shi L; Gao F; Sun W; Wang B; Guo W; Cheng L; Li Z; Wang W
    Osteoporos Int; 2017 Oct; 28(10):2945-2953. PubMed ID: 28685283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-energy extracorporeal shockwave therapy (ESWT) improves metaphyseal fracture healing in an osteoporotic rat model.
    Mackert GA; Schulte M; Hirche C; Kotsougiani D; Vogelpohl J; Hoener B; Fiebig T; Kirschner S; Brockmann MA; Lehnhardt M; Kneser U; Harhaus L
    PLoS One; 2017; 12(12):e0189356. PubMed ID: 29232698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone Turnover Markers and Bone Mineral Density to Predict Osteoporotic Fractures in Older Women: A Retrospective Comparative Study.
    Qu XL; Zheng B; Chen TY; Cao ZR; Qu B; Jiang T
    Orthop Surg; 2020 Feb; 12(1):116-123. PubMed ID: 31880071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in bone mass and bone turnover following distal forearm fracture.
    Ingle BM; Hay SM; Bottjer HM; Eastell R
    Osteoporos Int; 1999; 10(5):399-407. PubMed ID: 10591838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracorporeal shockwave therapy (ESWT) ameliorates healing of tibial fracture non-union unresponsive to conventional therapy.
    Haffner N; Antonic V; Smolen D; Slezak P; Schaden W; Mittermayr R; Stojadinovic A
    Injury; 2016 Jul; 47(7):1506-13. PubMed ID: 27158008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone mineral density: serum markers of bone turnover and their relationships in peritoneal dialysis.
    Negri AL; Barone R; Quiroga MA; Bravo M; Marino A; Fradinger E; Bogado CE; Zanchetta JR
    Perit Dial Int; 2004; 24(2):163-8. PubMed ID: 15119637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High bone turnover is associated with accelerated bone loss but not with increased fracture risk in men aged 50 and over: the prospective MINOS study.
    Szulc P; Montella A; Delmas PD
    Ann Rheum Dis; 2008 Sep; 67(9):1249-55. PubMed ID: 18065499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: the OFELY study.
    Garnero P; Sornay-Rendu E; Claustrat B; Delmas PD
    J Bone Miner Res; 2000 Aug; 15(8):1526-36. PubMed ID: 10934651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of low-dose alendronate treatment on bone mineral density and bone turnover markers in Chinese postmenopausal women with osteopenia and osteoporosis.
    Li M; Zhang ZL; Liao EY; Chen DC; Liu J; Tao TZ; Wu W; Xia WB; Lu YJ; Sheng ZF; Lu CY; Meng GL; Xu L; Zhang WJ; Hu YY; Xu L
    Menopause; 2013 Jan; 20(1):72-8. PubMed ID: 22968256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in bone mass and bone turnover following ankle fracture.
    Ingle BM; Hay SM; Bottjer HM; Eastell R
    Osteoporos Int; 1999; 10(5):408-15. PubMed ID: 10591839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of bone metabolism markers during the healing of osteoporotic versus nonosteoporotic metaphyseal long bone fractures: a matched pair analysis.
    Kolios L; Hitzler M; Moghaddam A; Takur C; Schmidt-Gayk H; Höner B; Lehnhardt M; Grützner P; Wölfl C
    Eur J Trauma Emerg Surg; 2012 Aug; 38(4):457-62. PubMed ID: 26816128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone mineral density, bone turnover markers and fractures in patients with indolent systemic mastocytosis.
    Rossini M; Zanotti R; Bonadonna P; Artuso A; Caruso B; Schena D; Vecchiato D; Bonifacio M; Viapiana O; Gatti D; Senna G; Riccio A; Passalacqua G; Pizzolo G; Adami S
    Bone; 2011 Oct; 49(4):880-5. PubMed ID: 21782049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study of bone mineral density and serum bone turnover markers in newly diagnosed systemic lupus erythematosus patients].
    Yao HH; Tang SM; Wang ZM; Zhang X; Chen XY; Gao L; Liu J; Dai YJ; Hu ZH; Zhang XW; Li ZG
    Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Dec; 50(6):998-1003. PubMed ID: 30562771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Extracorporal shock wave therapy for the treatment of pseudarthrosis : New experiences with an old technology].
    Everding J; Freistühler M; Stolberg-Stolberg J; Raschke MJ; Garcia P
    Unfallchirurg; 2017 Nov; 120(11):969-978. PubMed ID: 27638552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomised, double-blinded, placebo-controlled, trial to determine the individual response in bone turnover markers to lasofoxifene therapy.
    Rogers A; Glover SJ; Eastell R
    Bone; 2009 Dec; 45(6):1044-52. PubMed ID: 19665601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in bone turnover markers and bone mineral density after radiofrequency ablation for mild primary hyperparathyroidism: a prospective cohort study.
    Han Z; Xue Y; Liang L; Xie J; Zhou Z
    Quant Imaging Med Surg; 2024 Jun; 14(6):3828-3836. PubMed ID: 38846300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.